GHK-Cu is a naturally occurring tripeptide, Gly-His-Lys (hence the name), that binds copper ions
And while these trials are important to understanding the safety and efficacy of drugs, "no randomized controlled trial" is not the same as "no evidence." We have the accumulated experience of thousands of clinicians who have prescribed these compounds for nearly a decade and watched real patients get better in real time
While the current data is promising, more extensive clinical trials and research are necessary to fully understand and harness BPC 157s potential
- Coupon and reward points cannot be used together
Their combined ability to inhibit tyrosinase has led to popularity as a skinbrightening duo, but the evidence supporting intravenous use in healthy people is limited, and the potential risks are significant
Brett Brechner, DO, offers medically supervised GHK-Cu therapy as a subcutaneous injection or an oral capsule